Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study.

Bergman J, Burman J, Gilthorpe JD, Zetterberg H, Jiltsova E, Bergenheim T, Svenningsson A.

Neurology. 2018 Oct 10. pii: 10.1212/WNL.0000000000006500. doi: 10.1212/WNL.0000000000006500. [Epub ahead of print]

PMID:
30305449
2.

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.

Mao F, Holmlund C, Faraz M, Wang W, Bergenheim T, Kvarnbrink S, Johansson M, Henriksson R, Hedman H.

Oncogenesis. 2018 Feb 2;7(2):13. doi: 10.1038/s41389-017-0012-8.

3.

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.

Bergman J, Dring A, Zetterberg H, Blennow K, Norgren N, Gilthorpe J, Bergenheim T, Svenningsson A.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 2;3(5):e271. doi: 10.1212/NXI.0000000000000271. eCollection 2016 Oct.

4.

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.

Al Nimer F, Elliott C, Bergman J, Khademi M, Dring AM, Aeinehband S, Bergenheim T, Romme Christensen J, Sellebjerg F, Svenningsson A, Linington C, Olsson T, Piehl F.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 7;3(1):e191. doi: 10.1212/NXI.0000000000000191. eCollection 2016 Feb.

5.

Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.

Svenningsson A, Bergman J, Dring A, Vågberg M, Birgander R, Lindqvist T, Gilthorpe J, Bergenheim T.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 26;2(2):e79. doi: 10.1212/NXI.0000000000000079. eCollection 2015 Apr.

6.

Blood Metabolomic Predictors of 1-Year Outcome in Subarachnoid Hemorrhage.

Sjöberg RL, Bergenheim T, Mörén L, Antti H, Lindgren C, Naredi S, Lindvall P.

Neurocrit Care. 2015 Oct;23(2):225-32. doi: 10.1007/s12028-014-0089-2.

PMID:
25667130
7.

The efficacy of P6 acupressure with sea-band in reducing postoperative nausea and vomiting in patients undergoing craniotomy: a randomized, double-blinded, placebo-controlled study.

Nilsson I, Karlsson A, Lindgren L, Bergenheim T, Koskinen LO, Nilsson U.

J Neurosurg Anesthesiol. 2015 Jan;27(1):42-50. doi: 10.1097/ANA.0000000000000089.

PMID:
24978062
8.

Loud noise exposure and acoustic neuroma.

Fisher JL, Pettersson D, Palmisano S, Schwartzbaum JA, Edwards CG, Mathiesen T, Prochazka M, Bergenheim T, Florentzson R, Harder H, Nyberg G, Siesjö P, Feychting M.

Am J Epidemiol. 2014 Jul 1;180(1):58-67. doi: 10.1093/aje/kwu081. Epub 2014 Apr 30.

PMID:
24786799
9.

Long-term mobile phone use and acoustic neuroma risk.

Pettersson D, Mathiesen T, Prochazka M, Bergenheim T, Florentzson R, Harder H, Nyberg G, Siesjö P, Feychting M.

Epidemiology. 2014 Mar;25(2):233-41. doi: 10.1097/EDE.0000000000000058.

PMID:
24434752
10.

[More active treatment is necessary in spontaneous intracerebral hematomas. Acute management in Västerbotten compared with international guidelines].

Bergenheim T, Lagerström E, Andersson M.

Lakartidningen. 2013 Oct 23-29;110(43-44):1920-5. Swedish. No abstract available.

PMID:
24340434
11.

EGFR gene variants are associated with specific somatic aberrations in glioma.

Wibom C, Ghasimi S, Van Loo P, Brännström T, Trygg J, Lau C, Henriksson R, Bergenheim T, Andersson U, Rydén P, Melin B.

PLoS One. 2012;7(12):e47929. doi: 10.1371/journal.pone.0047929. Epub 2012 Dec 7.

12.

Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors.

Asklund T, Kvarnbrink S, Holmlund C, Wibom C, Bergenheim T, Henriksson R, Hedman H.

Anticancer Res. 2012 Jul;32(7):2407-13.

PMID:
22753697
13.

Role of tobacco use in the etiology of acoustic neuroma.

Palmisano S, Schwartzbaum J, Prochazka M, Pettersson D, Bergenheim T, Florentzson R, Harder H, Mathiesen T, Nyberg G, Siesjö P, Feychting M.

Am J Epidemiol. 2012 Jun 15;175(12):1243-51. doi: 10.1093/aje/kwr465. Epub 2012 Apr 19.

14.

Long term follow-up of deep brain stimulation of the caudal zona incerta for essential tremor.

Fytagoridis A, Sandvik U, Aström M, Bergenheim T, Blomstedt P.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):258-62. doi: 10.1136/jnnp-2011-300765. Epub 2011 Dec 28.

PMID:
22205676
15.

Bilateral deep brain stimulation for cervical dystonia in patients with previous peripheral surgery.

Capelle HH, Blahak C, Schrader C, Baezner H, Hariz MI, Bergenheim T, Krauss JK.

Mov Disord. 2012 Feb;27(2):301-4. doi: 10.1002/mds.24022. Epub 2011 Dec 15.

PMID:
22173964
16.

A family with a hereditary form of torsion dystonia from northern Sweden treated with bilateral pallidal deep brain stimulation.

Blomstedt P, Hariz MI, Tisch S, Holmberg M, Bergenheim TA, Forsgren L.

Mov Disord. 2009 Dec 15;24(16):2415-9. doi: 10.1002/mds.22842.

PMID:
19890997
17.

Liquid ionization chamber calibrated gel dosimetry in conformal stereotactic radiotherapy of brain lesions.

Björeland A, Lindvall P, Karlsson A, Gustavsson H, Bäck SA, Karlsson M, Bergenheim TA.

Acta Oncol. 2008;47(6):1099-109. doi: 10.1080/02841860801888781.

PMID:
18607837
18.
19.

[Registration on regional basis of patients with primary brain tumors. Regional differences disclosed].

Bergenheim T, Malmström A, Bolander H, Michanek A, Stragliotto G, Damber L, Björ O, Henriksson R.

Lakartidningen. 2007 Jan 31-Feb 6;104(5):332-8, 340-1. Swedish. No abstract available.

PMID:
17328357
20.

Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.

Guo D, Nilsson J, Haapasalo H, Raheem O, Bergenheim T, Hedman H, Henriksson R.

Acta Neuropathol. 2006 Mar;111(3):238-46. Epub 2006 Mar 11.

PMID:
16532360
21.

The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.

Vallbo C, Bergenheim T, Hedman H, Henriksson R.

J Neurooncol. 2002 Jan;56(2):143-8.

PMID:
11995815
22.

The bleb formation of the extracellular pseudopodia; early evidence of microtubule depolymerization by estramustine phosphate in glioma cell; in vitro study.

Yoshida D, Noha M, Watanabe K, Bergenheim T, Henriksson R, Teramoto A.

J Neurooncol. 2001 Mar;52(1):37-47.

PMID:
11451201
23.

Retinopathy in diabetic patients aged 15-50 years in the county of Umeå, Sweden.

Larsson LI, Alm A, Bergenheim T, Lithner F, Bergström R.

Acta Ophthalmol Scand. 1999 Aug;77(4):430-6.

24.

[Modified cost-benefit analysis takes equity into consideration. Treatment of brain tumors is more cost-effective than hip replacement].

Lindholm L, Henriksson R, Rosén M, Bergenheim T, Salander P.

Lakartidningen. 1999 Jun 2;96(22):2749-54. Swedish.

PMID:
10388304
25.

Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.

Bergström P, Johnsson A, Bergenheim T, Henriksson R.

J Neurooncol. 1999 Mar;42(1):13-21.

PMID:
10360475
26.
27.

[SBU is wrong on radiotherapy of brain tumors. Early postoperative therapy prolongs the symptom-free period].

Henriksson R, Berg G, Andreasson L, Bergenheim T, Blomqvist E, Edekling T, Malmström A, Malmström P, Skagerberg G.

Lakartidningen. 1997 Sep 24;94(39):3423-4. Swedish. No abstract available.

PMID:
9379814
28.

[Foot changes are common in patients with diabetes type 1. Foot casts may reduce the risk of plantar wounds].

Borssén B, Bergenheim T, Lithner F.

Lakartidningen. 1997 Aug 20;94(34):2822-4. Swedish. No abstract available.

PMID:
9303992
29.

Effects of cisplatin and amphotericin B on DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.

Bergström P, Johnsson A, Cavallin-Ståhl E, Bergenheim T, Henriksson R.

Eur J Cancer. 1997 Jan;33(1):153-9.

PMID:
9071915
30.
31.

The creation of protection and hope in patients with malignant brain tumours.

Salander P, Bergenheim T, Henriksson R.

Soc Sci Med. 1996 Apr;42(7):985-96.

PMID:
8730904
32.
33.
34.

Long-term memory deficits in patients with malignant gliomas.

Salander P, Karlsson T, Bergenheim T, Henriksson R.

J Neurooncol. 1995;25(3):227-38.

PMID:
8592173
35.

[Penny-wise and pound-foolish? Neurosurgery is needed for care of cranial injuries].

Algers G, Bergenheim T.

Lakartidningen. 1993 Jun 9;90(23):2204-5. Swedish. No abstract available.

PMID:
8502078
36.

[Hypofractionation. A method for stereotaxic radiation of major brain lesions with linear accelerator].

Hariz M, Löfroth PO, Bergenheim T, Fagerlund M, Henriksson R.

Lakartidningen. 1993 May 5;90(18):1744, 1747-50. Swedish.

PMID:
8492629
37.

Comparison between radiosurgery and stereotactic fractionated radiation for the treatment of brain metastases.

De Salles AA, Hariz M, Bajada CL, Goetsch S, Bergenheim T, Selch M, Holly FE, Solberg T, Becker DP.

Acta Neurochir Suppl (Wien). 1993;58:115-8.

PMID:
8109272
38.

Sensory thresholds for vibration, perception and pain in diabetic patients aged 15-50 years.

Bergenheim T, Borssén B, Lithner F.

Diabetes Res Clin Pract. 1992 Apr;16(1):47-52.

PMID:
1576931
39.

Extensor digitorum brevis in diabetic neuropathy: a controlled evaluation in diabetic patients aged 15-50 years.

Lithner F, Bergenheim T, Borssén B.

J Intern Med. 1991 Nov;230(5):449-53.

PMID:
1940781
40.

Estramustine binding protein in human brain-tumor tissue.

von Schoultz E, Bergenheim T, Grankvist K, Henriksson R.

J Neurosurg. 1991 Jun;74(6):962-4.

PMID:
1709687
41.

[CNS hemorrhage after drug induced thrombolysis in suspected myocardial infarction].

Rabow L, Bergenheim T, Fagerlund M.

Lakartidningen. 1991 Feb 13;88(7):492, 494-5. Swedish. No abstract available.

PMID:
1999997
42.

The epidemiology of foot lesions in diabetic patients aged 15-50 years.

Borssén B, Bergenheim T, Lithner F.

Diabet Med. 1990 Jun;7(5):438-44.

PMID:
2142042
43.

[Talking to the comatose patient!].

Bergenheim T, Henriksson R, Knibestöl M.

Lakartidningen. 1989 Jun 14;86(24):2306-7. Swedish. No abstract available.

PMID:
2747363

Supplemental Content

Loading ...
Support Center